A programmer of direct recognition molecular diagnostic lab tests for medical applications.

.. Adnavance Technologies to present its DNA direct detection technology in the AdvaMed 2009 Adnavance Systems Inc., a programmer of direct recognition molecular diagnostic lab tests for medical applications, announced today that Randy White, Ph.D. Ceo, will present initial data supporting immediate detection of DNA targets in human being clinical samples during business presentations at the following conferences: AdvaMed 2009 on Tuesday, 13 October, 2009 at 10:00 a.m. Eastern Period at the Walter E. Washington Convention Center in Washington, D.C. BIOCOM’s 4th Annual Investor Conference on Mon, 26 October, 2009 at 10:00 a.m. Pacific Time at the Hyatt Regency La Jolla in San Diego, California. The hallmark of Adnavance’s direct detection technology is its simplicity; it doesn’t require PCR, light detection, or sample pre-treatment.Measured the resistive index in segmental renal arteries, whereas we measured it in the interlobar arteries. Although the Doppler signals measured in segmental arteries aren’t substantially different from those measured in interlobar arteries,30 further investigation of the potential effect of the technique used to gauge the resistive index is certainly important. In our study, the intrarenal resistive index was significantly higher during biopsies performed because of graft dysfunction than at protocol-specified biopsy time factors, a discovering that is consistent with the observed association between allograft dysfunction and an increased resistive index in previous studies.31,32 The intrarenal resistive index was connected with intrarenal histologic findings only when the biopsy was performed because of graft dysfunction, with an elevated resistive index connected with acute tubular necrosis and acute antibody-mediated rejection.